CVS Health Corporation (CVS) currently holds a consensus from Wall Street analysts, with 20 out of 24 experts recommending it as a top pick as of late April 2026. Trading near $78.38 , the stock is widely considered an attractive value play due to its low valuation relative to its $400+ billion annual revenue and robust cash flow. Key Investment Highlights
AI responses may include mistakes. For financial advice, consult a professional. Learn more Is CVS Health the Ultimate Value Stock to Buy Right Now? should i buy cvs stock
Some analysts project a 12-month price target averaging , implying over 20% upside. CVS Health Corporation (CVS) currently holds a consensus